Bioretec, a maker of absorbable orthopedic implants, has named Tuukka Paavola as its new chief financial officer (CFO). Paavola will take office on January 20, reporting to chief executive officer (CEO) Sarah van Hellenberg Hubar-Fisher and joining the company’s management team.

Paavola boasts over two decades of experience in finance, capital markets, and strategic planning. He was previously CFO of Nightingale Health as well as in various leadership positions at Nordea Bank.

In his new role, he will spearhead all financial operations, including planning, reporting, and compliance. Paavola will also play a crucial role in crafting the Tampere, Finland-based company’s long-term financial strategy.

“We are excited to welcome Tuukka to Bioretec, and we look forward to his leadership and contributions as we continue to advance our mission to become a global leader in absorbable implants focused on healing. Tuukka join us at a pivotal and exciting time in our journey as a company and we look forward to his contributions in realizing our goals,” said CEO Sarah van Hellenberg Hubar-Fisher. “We also want to express our gratitude to Anne-Mari Matikainen, who has served as Interim CFO during the past months and supported us during a critical transition period for the company. Anne-Mari will continue to support the transition process until the February 13, ensuring a smooth handover and continuity in our financial operations.”

Sarah van Hellenberg Hubar-Fisher became Bioretec’s chief executive in August 2025. She’s on the Board of Global Surgical Initiatives, a New York-based nonprofit focused on delivering sustainable surgical care to underserved communities. Her career includes senior leadership roles at Johnson & Johnson, as well as a Venture Partner at Nina Capital (Spain) and Growth Science Ventures (U.S.)

Last month, the company revealed its magnesium alloy technology-based, biodegradable RemeOs DrillPin earned breakthrough device status from the U.S. Food and Drug Administration (FDA).

“I am delighted for the opportunity to join Bioretec at this very exciting moment and help the company in continuing its global growth journey,” said Paavola.